Summary

What it measures:

What It Measures and Conditions and Test Variations Included in This Summary:

The IMPROVE VTE Risk Model is an assessment tool that is used to discriminate risk of developing validated venous thromboembolism (VTE) in patients who are critically ill, based on clinical variables.¹ This summary measures an estimate of the probability of major or clinically important in-hospital bleeding from the time of hospital admission up to 14 days following admission, and an estimate of the probability of clinically evident acute venous thromboembolism from the time of hospital admission to discharge, based on risk factors that are known (or that can be reasonably estimated) at the time of hospital admission. This summary contains information on use of this test on patients who were hospitalized for an acute medical illness in 52 hospitals in 12 countries (total of 15,155 patients).²

Individual clinical information is placed into the calculator using pop-up menus and checkbox indicators. The results boxes display the probabilities of acute VTE and new clinically important bleeding.²

ICF Domain(s):    

List 1 or more of the following that the test measures:

• Body Function
• Activity                                                               

ICF Categories:

List one or more of the following that the test measures:

• Probability of an acute venous thromboembolism
• Probability of a clinically important bleeding

Target Population:

Adult